CClinicalTrials.gg
CompletedNCT06273514Updated Feb 22, 2024

Comparison the Effects of TECAR With Dry Needling in the Treatment of Myofascial Trigger Points

An interventional study of TECAR and Dry needling in Myofascial Pain Syndrome of Neck, Myofascial Trigger Point Syndrome and Myofascial Trigger Point Pain, sponsored by Medical University of Silesia. Completed at 1 site in Poland. Open to male participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-02-22.

Sponsored by Medical University of Silesia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Dec 2020, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
Male
01

Study summary

The aim of the study is to assess the effectiveness of dry needling (DN) and capacitive and resistive transfer of energy (TECAR) therapy in the treatment of myofascial trigger points (MTrPs) as well comparison of their efficacy.

Research hypothesis:

Capacitive and resistive energy transfer therapy is comparable to dry needling therapy for the treatment of myofascial trigger points.

It is estimated that the presence of trigger points is the main cause of pain in 30-85% of patients visiting primary health care facilities and pain management clinics. The presence of trigger points may significantly affect the patient's functional status and daily functioning. Recently, diagnostic criteria and methods of treating trigger points have evolved significantly. However, the usefulness of different imaging methods in the diagnosis of trigger points has not yet been established. Despite numerous studies, the long-term effectiveness of the dry needling method is still unknown. Furthermore, there is no available research on the short- and long-term effectiveness of capacitive and resistive energy transfer therapy in the treatment of trigger points.

Therefore, the objectives of the work were:

Determination and comparison of the short- and long-term effects of capacitive and resistive energy transfer therapy and the dry needling technique of myofascial trigger points located in the upper trapezius muscle (UT) on the strength, neck range of motion and pain intensity within this muscle.

The study is planned to include a group of 26 men aged 25 to 45 who suffer from pain caused by the presence of myofascial trigger points in the upper trapezius muscle. The subjects will be divided into two groups of equal number of people. The first group will undergo therapy using the dry needling technique, while the second group will undergo capacitive and resistive energy transfer therapy.

In order to determine the immediate effects of capacitive and resistive energy transfer therapy and dry needling techniques, measurements of muscle strength, the intensity of pain in the upper trapezius muscle and neck range of motion will be performed before and after each therapeutic session (2 session in 2 weeks are planed). In turn, to determine the long-term effects of capacitive and resistive energy transfer therapy and dry needling, the next above-mentioned measurements will be performed four weeks after the end of first therapy.

02

Conditions studied

  • Myofascial Pain Syndrome of Neck
  • Myofascial Trigger Point Syndrome
  • Myofascial Trigger Point Pain

Keywords

  • myofascial trigger point
  • myofascial pain syndrome
  • TECAR therapy
  • dry needling
  • upper trapezius.
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 22 is below the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Medical University of Silesia is the lead sponsor of 111 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • sex male
  • age 25-45
  • manually confirmed active MTrP in the upper trapezius

Exclusion criteria

Exclusion Criteria:

  • MTrP therapy in the upper trapezius region during the last year
  • history of neck trauma
  • history of cervical spine surgeries
  • history of humeral joint surgeries
  • cervical radiculopathy
  • chronic and acute diseases of the cardiovascular system
  • chronic and acute diseases of the respiratory system
  • chronic and acute diseases of the nervous systems
  • endocrine disturbances
  • skin lesions in upper trapezius area
  • acute inflammation
  • cancer
  • BMI > 30 kg/m2.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    TECAR

    TECAR therapy is a non-invasive method for treating musculoskeletal system disorders based on the application of high-frequency current (300 kHz - 1 MHz)

    Other: TECAR

  • Experimental
    Dry needling

    Dry needling, a form of intramuscular stimulation, is a therapeutic intervention employed in physiotherapy and sports medicine. It entails the precise insertion of fine needles into specific myofascial trigger points, taut bands of skeletal muscle, or connective tissue without the administration of pharmacological agents.

    Other: Dry needling

Interventions

  • OtherTECAR

    TECAR therapy performs using a WINBACK® 1s device (Daeyang Medical Co. Ltd, South Korea) with a maximum power of 100W. A 500 kHz frequency capacitive electrode is applied directly to the active MTrP in the UT. The closed electrode is placed distally on the arm. Lowpulse modulation use during treatment with half-second pauses. This enables the application of the current directly into the MTrP without enrolling the entire muscle. The single exposure last for 10 min. The current dose participant-dependent and ranged from 40 to 60% (100% = 100 Watts). Each time, before and after treatment, and 30 days after the first therapy, the following features will be asses: pain intensity, muscle strength, and ROM.

    Also known as: capacitive and resistive transfer of energy

  • OtherDry needling

    Dry needling performs using SOMA needles (25 mm x 0.3 mm). During the therapy, the participant is in a prone position. The affected UT region is disinfect before needling. The taut band localizes between the thumb and index finger of the researcher. The needle within the plastic guide tube is place over the MTrP at the UT. The needle directly inserts into the MTrP. A local twitch response confirms the accuracy of the puncture. Needling performs using Hong's "fast in, fast out" technique. The needle will be withdrawn if no twitching will observe.

    Also known as: DN

06

What researchers measure

Primary outcomes

  1. Pain - Pressure pain threshold (PPT)

    Defined as the minimum force applied which induces pain, asses using an algometer BioFEET V3 (MusTec, Almere, Netherlands). The head of the algometer was placed on the MTrP in the upper trapezius (UT) and then pressed until the participant verbally expressed their PPT.

    Time frame: The measurements were performed three times with a 30-second break. The results are presented as the mean value of these measurements and are expressed in kg/m2.

  2. Pain - numerical rating scale (NRS)

    This pain screening tool uses a 0-10 scale, with 0 indicating no pain and 10 indicating the worst imaginable pain.

    Time frame: Up to 3 minutes before and up to 3 minutes after each interventions

Secondary outcomes

  1. Muscle strength

    Measures using a dynamometer (BioFEET V3; -MusTec, Muscle Dynamic Technology BV, Louis Chrispijnstraat1, Netherlands 1325 PC ALMERE). We assume that scapula elevation is the indicatory movement for the UT. During the assessment, the humeral joint remained in a natural position with proximal stabilization. The head of the dynamometer will be then placed on the acromion. The physiotherapist resisted active movements to provoke isometric contraction of the UT.

    Time frame: Measurements will be perform three times on both sides of the body up to 5 minutes before and up to 5 minutes after each interventions . The highest results obtained for statistical analysis and will be expressed as kG (kilogram force)

  2. Cervical spine range of motion (ROM)

    Cervical spine ROM was measured using a goniometer (BASEline). The following movements were assessed: flexion, extension, rotation, and side bending. During the measurements the participants sit. While measuring cervical spine flexion and extension, the axis of the goniometer is place on the auricle opening. During the rotation, the axis of the goniometer is place at the top of the skull. Side bends measures with the goniometer axis placed on the spinal process of the axis (C2).

    Time frame: Each movement will be perform three times up to 10 minutes before and up to 10 minutes after each interventions. The results are present as the mean value of these measurements and are express in degrees (°)

07

Study locations

1 site
  • Medical fit
    Ruda Śląska, Śląsk 41-717, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06273514
Lead sponsor
Medical University of Silesia
Responsible party
Tomasz Piętka (School of Health Sciences in Katowice, Department of Physical Medicine, Chair of Physiotherapy, Medical University of Silesia in Katowice, Poland, Medical University of Silesia) — Principal investigator
First posted
Feb 22, 2024
Start date
Dec 1, 2020
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Feb 22, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion